1. "2011"
Formats
  1. Journal Article (2141)
  2. Meeting Abstract (988)
  3. Book Section (224)
  4. Conference Paper (18)
  5. Book Whole (11)
Groups
  1. Department of Medicine (1176)
  2. Surgery (803)
  3. GSK Faculty (796)
  4. Solid Tumor Oncology Division (659)
  5. Sloan Kettering Institute Faculty (606)
  6. Survivorship Research (542)

More Groups

People
  1. Robert Soslow (64)
  2. Clifford Hudis (60)
  3. Mithat Gonen (54)
  4. Marc Ladanyi (52)
  5. Robert Motzer (52)
  6. Valerie Rusch (47)

More People

Years
  1. 2011 (3382)
Publications
  1. Journal of Clinical Oncology (319)
  2. Blood (147)
  3. Cancer Research (122)
  4. International Journal of Radiation Oncology, Biology, Physics (104)
  5. Modern Pathology (70)
  6. Laboratory Investigation (65)

More Publications

Publishers
  1. Elsevier Inc. (450)
  2. American Society of Clinical Oncology (327)
  3. Springer (231)
  4. American Association for Cancer Research (180)
  5. Nature Publishing Group (157)
  6. Wiley Blackwell (154)

More Publishers

Results (3382)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic and functional investigation of germline JAK2 alleles that predispose to myeloproliferative neoplasms
    Meeting Abstract

    Schram, A. M.; Xu, X.; Kilpivaara, O.; Mukherjee, S.; Viny, A. D.; Guryanova, O.; Klein, R. J.; Levine, R. L.
    Blood (2011)

    Fulltext@MSK | Save
  • A cytotoxic human monoclonal antibody recognizing cell surface WT1 peptide/HLA-A2 complexes
    Meeting Abstract

    Scheinberg, D. A.; Dao, T.; Yan, S. ; Zhou, L.; Korontsvit, T.; Zakhaleva, V.; Curcio, M.; Liu, C.
    Blood (2011)

    Fulltext@MSK | Save
  • MicroRNAs mediate resistance to tyrosine kinase inhibitors in Philadelphia-positive B-ALL by down-regulating key tumor suppressors
    Meeting Abstract

    Schatz, J. H.; Mavrakis, K.; Wolfe, A. L.; Wendel, H. G.
    Blood (2011)

    Fulltext@MSK | Save
  • Non-myeloablative allogeneic hematopoietic stem cell transplantation with low-dose total body irradiation and peri-transplant rituximab for B cell non-Hodgkin lymphoma: Favorable disease control in chemosensitive patients
    Meeting Abstract

    Sauter, C. S.; Papadopoulos, E. B.; Perales, M. A.; Jakubowski, A. A.; Goldberg, J. D.; Koehne, G.; Lechner, L.; Moskowitz, C. H.; Giralt, S.; Barker, J. N.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • T-cell depleted (TCD) hematopoietic stem cell (HSC) boosts from the original donor without conditioning for poor graft function (PGF) following allogeneic hematopoietic stem cell transplants (HSCT)
    Meeting Abstract

    Rosenzweig, M. A.; Kernan, N. A.; Small, T. N.; Maloy, M.; Jakubowski, A. A.; Papadopoulos, E. B.; Perales, M. A.; Boulad, F.; Giralt, S.; Young, J. W.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • HSP70 inhibitor, YK5, ablates blast, progenitor and stem cell populations in primary acute myelogenous leukemia cells
    Meeting Abstract

    Rico, J. F.; Sharma, K. K.; Kang, Y. L.; Taldone, T.; Patel, H.; Brennan, S.; Zong, H. L.; Becker, M. W.; Roboz, G. J.; Chiosis, G.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Defibrotide (DF) in the treatment of hepatic veno-occlusive disease (VOD) in stem cell transplant (SCT) and non-SCT patients (Pts): Early intervention improves outcome - Updated results of a treatment IND expanded access protocol
    Meeting Abstract

    Richardson, P. G.; Smith, A. R.; Grupp, S. A.; Kernan, N. A.; Arai, S.; Haut, P. R.; Triplett, B. M.; Gillio, A. P. 3rd; Symons, H. J.; Adams, R. H.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Dynamics of mutant alleles in patients with advanced essential thrombocythernia (ET) or polycythemia (PV) during pegylated interferon-alfa-2A (PEG-IFN-alpha-2A; pegasys) therapy
    Meeting Abstract

    Quintas-Cardama, A.; Abdel-Wahab, O.; Levine, R. L.; Manshouri, T.; Roupie, A. L.; Kantarjian, H. M.; Verstovsek, S.
    Blood (2011)

    Fulltext@MSK | Save
  • Phase II multicenter trial of lenalidomide: Clinical and immunomodulatory effects in patients with CTCL
    Meeting Abstract

    Querfeld, C.; Rosen, S. T.; Guitart, J.; Duvic, M.; Kim, Y. H.; Goolsby, C.; Kuzel, T.
    Blood (2011)

    Fulltext@MSK | Save
  • A randomized phase II trial of fludarabine/melphalan 140 vs fludarabine/melphalan 100 followed by allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma
    Meeting Abstract

    Qazilbash, M.; Thall, P. F.; Liu, P.; Orlowski, R. Z.; Bashir, Q.; Shah, N.; Kebriaei, P.; Parmar, S.; Jones, R.; Hosing, C. M.; more...
    Blood (2011)

    Fulltext@MSK | Save